TY - JOUR
T1 - Beta blockade in the primary prevention of hypertensive cardiovascular events with focus on sudden cardiac death
AU - Kaplan, Norman M
PY - 1997/11/13
Y1 - 1997/11/13
N2 - Beta-adrenergic blocking agents are useful drugs in the treatment of hypertension. In multiple clinical trials, β blockers have been found to decrease the incidence of stroke and overall cardiovascular mortality. To provide maximal benefit, in particular, to blunt the early-morning surge in blood pressure associated with the increased circadian incidence of sudden cardiac death, the more cardioselective and longer-acting agents of this drug class are preferred.
AB - Beta-adrenergic blocking agents are useful drugs in the treatment of hypertension. In multiple clinical trials, β blockers have been found to decrease the incidence of stroke and overall cardiovascular mortality. To provide maximal benefit, in particular, to blunt the early-morning surge in blood pressure associated with the increased circadian incidence of sudden cardiac death, the more cardioselective and longer-acting agents of this drug class are preferred.
UR - http://www.scopus.com/inward/record.url?scp=0030667974&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0030667974&partnerID=8YFLogxK
U2 - 10.1016/S0002-9149(97)00834-5
DO - 10.1016/S0002-9149(97)00834-5
M3 - Article
C2 - 9375945
AN - SCOPUS:0030667974
SN - 0002-9149
VL - 80
SP - 20J-22J
JO - American Journal of Cardiology
JF - American Journal of Cardiology
IS - 9 B
ER -